Cellular Dynamics to Host iForum™ Meetings Focused on Human iPSC Research and Applications

12 Aug 2015
Lois Manton-O'Byrne, PhD
Executive Editor

Industry news

Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, will host the annual iForum™ 2015 Meeting: US on September 14-16 in Chicago, IL. With the rapidly growing interest in and use of iPSCs over recent years in drug discovery and cell therapy applications, iForum 2015 Meetings represent a natural evolution of the former CDI User Group Meetings. The iForum 2015 Meeting: Europe is slated to be held in Hamburg, Germany, on October 19.

iForum meetings, with the tagline Connect│Discover│Innovate, provide a unique opportunity to connect with thought leaders from academia, government, biotech and pharma. Attendees will discover new applications and innovative uses for induced pluripotent stem cell (iPSC)-derived human cells through interactive, data-driven presentations.

Session topics include disease modeling and drug discovery, toxicity, and tissue engineering and regenerative medicine. For a list of confirmed speakers, please refer to the meeting website. Registration is open for the iForum 2015 Meetings in Chicago and Germany. Scientific poster submissions are now being accepted for the iForum 2015 Meetings in both the Chicago and Germany locations.

iForum meetings include lunch roundtable sessions, which facilitate networking and learning. Topics include:

  • Regenerative medicine
  • in vitro clinical trials
  • Advantages and disadvantages of ready-made vs. homebrew iPSC-derived cells
  • The Comprehensive in vitro Proarrhythmia Assay (CIPA) initiative to replace the current S7B regulatory guideline
  • Screening
  • Central nervous system disease modeling
  • Liver disease modeling
  • Cardiac disease modeling
  • Skeletal muscular disease modeling

Sponsors of the iForum 2015 Meeting: US include Axion Biosystems, ACEA Bioscience, WiCell Research Institute, Hitachi, and Greiner Bio-One.

Attendees of the iForum 2015 Meeting: US will have the opportunity to judge photos of iCell® and MyCell® cells that are being submitted in a contest sponsored by CDI with the goal of using the winning images in a CDI 2016-2017 wall calendar. More information about the contest can be found on the CDI website. “We are very excited to bring together this esteemed group of scientists who are pushing the envelope in the use of iPSCs for drug discovery and therapeutic applications,” Cellular Dynamics CEO Kaz Hirao said. “We expect to see a lively, informative dialog as speakers and our audience engage in discussion and debate over these topics.”

Links

Tags

High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.High-Content ScreeningHigh-content screening (HCS), also known as high-content analysis (HCA), is a high-throughput technique used in drug discovery to identify substances that alter the phenotype of cells. HCS uses fluorescent microscopic imaging and automated image analysis to investigate cellular events such as apoptosis, cell viability, GPCR activation, oxide production, neurite outgrowth, and cell signaling. Find the best fluorescent labeling reagents, cellular assays, and high-content imaging systems in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. In Vitro DiagnosticsIn vitro diagnostics (IVD) involve testing samples outside the body, typically in a laboratory, to diagnose diseases or conditions. IVD technologies include blood tests, molecular assays, and other bodily fluid tests, enabling accurate diagnosis and monitoring of diseases. These tests are essential for guiding treatment decisions in clinical settings. Browse our peer-reviewed product directory to find the best IVD solutions; compare products, check reviews, and get pricing directly from manufacturers.Regenerative MedicineScreeningUsing robotics, data processing and control software, liquid handling devices and sensitive detectors, screening allows a researcher to quickly conduct millions of chemical, genetic or pharmacological tests.Liver DiseaseCardiovascular DiseaseCardiovascular disease refers to a group of disorders of the heart and blood vessels, including heart attacks, strokes, and high blood pressure. Early diagnosis and effective treatment are essential for improving patient outcomes. Explore cardiovascular disease research and diagnostic tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.